{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:20:07Z","timestamp":1792790407732,"version":"4.5.0"},"reference-count":48,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Blood Cancer UK","award":["12051"],"award-info":[{"award-number":["12051"]}],"id":[{"id":"https:\/\/ror.org\/0055acf80","id-type":"ROR","asserted-by":"crossref"}]},{"award":["12051"],"award-info":[{"award-number":["12051"]}],"id":[{"id":"https:\/\/ror.org\/0055acf80","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Cancer Research UK","award":["CRUK PDF"],"award-info":[{"award-number":["CRUK PDF"]}],"id":[{"id":"https:\/\/ror.org\/054225q67","id-type":"ROR","asserted-by":"crossref"}]},{"award":["CRUK PDF"],"award-info":[{"award-number":["CRUK PDF"]}],"id":[{"id":"https:\/\/ror.org\/054225q67","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Blood Cancer UK","award":["19013"],"award-info":[{"award-number":["19013"]}],"id":[{"id":"https:\/\/ror.org\/0055acf80","id-type":"ROR","asserted-by":"crossref"}]},{"award":["19013"],"award-info":[{"award-number":["19013"]}],"id":[{"id":"https:\/\/ror.org\/0055acf80","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multi-protein complex that has bipartite DNA binding through heterodimeric basic-helix-loop-helix (bHLH) and GATA proteins. To determine if degradation of LMO2 in the context of T cell acute leukaemias (T-ALL) has therapeutic potential, a chimeric intracellular antibody has been developed fusing an anti-LMO2 single-domain variable region with one of three E3 ligases to create biodegraders. The intracellular binary interaction of these biodegraders with LMO2 leads to its proteasomal degradation but, in addition, concomitant loss of bHLH proteins that associate with LMO2 in the DNA-binding complex. Chemical compound surrogates of the intracellular antibody paratope (called antibody-derived [Abd] compounds) have been modified to create proteolysis targeting chimeras (PROTACs) for orthogonal assays of effects of LMO2 degradation. These form a ternary complex with LMO2 and E3 ligase in leukaemia cells that induces degradation of LMO2 and is also accompanied by loss of associated bHLH proteins. This is accompanied by T-ALL growth inhibition, alterations in proteins involved in cell cycling and instigation of apoptosis. These effects do not occur in the absence of LMO2. Our work demonstrates that degradation of LMO2 affects T-ALL, and the lead compounds can eventually be developed into drugs for patient treatment. Our work describes methods for drug discovery starting with antibody fragments.<\/jats:p>","DOI":"10.7554\/elife.106699","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:30:40Z","timestamp":1754494240000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.106699","source":"Crossref","is-referenced-by-count":0,"title":["Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis"],"prefix":"10.7554","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-441X","authenticated-orcid":true,"given":"Naphannop","family":"Sereesongsaeng","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043jzw605","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Cancer Research, Division of Cancer Therapeutics","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Carole","family":"Bataille","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Chemistry, Chemistry Research Laboratory, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Angela","family":"Russell","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Chemistry, Chemistry Research Laboratory, University of Oxford","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pharmacology, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2643-3897","authenticated-orcid":true,"given":"Nicolas","family":"Bery","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Weatherall Institute of Molecular Medicine, MRC Molecular Haematology Unit, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-1657","authenticated-orcid":true,"given":"Fernando J","family":"Sialana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043jzw605","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Cancer Research","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Jyoti","family":"Choudhary","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043jzw605","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Cancer Research","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Ami","family":"Miller","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043jzw605","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Cancer Research, Division of Cancer Therapeutics","place":["London, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Weatherall Institute of Molecular Medicine, MRC Molecular Haematology Unit, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4982-2609","authenticated-orcid":true,"given":"Terence","family":"Rabbitts","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043jzw605","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Cancer Research, Division of Cancer Therapeutics","place":["London, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Weatherall Institute of Molecular Medicine, MRC Molecular Haematology Unit, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170204","type":"journal-article","article-title":"Visualizing the complex functions and mechanisms of the anaphase promoting complex\/cyclosome (APC\/C)","volume":"7","author":"Alfieri","year":"2017","journal-title":"Open Biology"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020251","type":"journal-article","article-title":"Pan-Cancer analyses reveal genomic features of FOXM1 overexpression in cancer","volume":"11","author":"Barger","year":"2019","journal-title":"Cancers"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","type":"journal-article","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nature Reviews Drug Discovery"},{"key":"bib4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17022-w","type":"journal-article","article-title":"A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS","volume":"11","author":"Bery","year":"2020","journal-title":"Nature Communications"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg1950","type":"journal-article","article-title":"A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2","volume":"7","author":"Bery","year":"2021","journal-title":"Science Advances"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4324","type":"journal-article","article-title":"A cell-based screening method using an intracellular antibody for discovering small molecules targeting hard-to-drug proteins","volume":"12","author":"Bery","year":"2022","journal-title":"Bio-Protocol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/j.1460-2075.1988.tb02825.x","type":"journal-article","article-title":"The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15","volume":"7","author":"Boehm","year":"1988","journal-title":"The EMBO Journal"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1073\/pnas.88.10.4367","type":"journal-article","article-title":"The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13","volume":"88","author":"Boehm","year":"1991","journal-title":"PNAS"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1039\/d1cb00011j","type":"journal-article","article-title":"Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation","volume":"2","author":"Bond","year":"2021","journal-title":"RSC Chemical Biology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1021\/ja209924v","type":"journal-article","article-title":"Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL\/HIF-1\u03b1 interaction","volume":"134","author":"Buckley","year":"2012","journal-title":"Journal of the American Chemical Society"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","type":"journal-article","article-title":"Proteolysis-targeting chimeras as therapeutics and tools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0092-8674(91)90105-8","type":"journal-article","article-title":"Oncogenic conversion of transcription factors by chromosomal translocations","volume":"66","author":"Cleary","year":"1991","journal-title":"Cell"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217889","type":"journal-article","article-title":"Intrinsically disordered proteins and structured proteins with intrinsically disordered regions have different functional roles in the cell","volume":"14","author":"Deiana","year":"2019","journal-title":"PLOS ONE"},{"key":"bib14","first-page":"1812","type":"journal-article","article-title":"Molecular characterization of a chromosome translocation breakpoint t(11;14)(p13;q11) from the cell line KOPT-K1","volume":"9","author":"Dong","year":"1995","journal-title":"Leukemia"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.celrep.2013.06.008","type":"journal-article","article-title":"Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets","volume":"4","author":"El Omari","year":"2013","journal-title":"Cell Reports"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","type":"journal-article","article-title":"BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design","volume":"15","author":"Farnaby","year":"2019","journal-title":"Nature Chemical Biology"},{"key":"bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/j.1460-2075.1996.tb00439.x","type":"journal-article","article-title":"Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice","volume":"15","author":"Larson","year":"1996","journal-title":"The EMBO Journal"},{"key":"bib18","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00652-19","type":"journal-article","article-title":"LDB1 enforces stability on direct and indirect oncoprotein partners in Leukemia","volume":"40","author":"Layer","year":"2020","journal-title":"Molecular and Cellular Biology"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1039\/d2cs00193d","type":"journal-article","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chemical Society Reviews"},{"key":"bib20","doi-asserted-by":"publisher","DOI":"10.1038\/srep36050","type":"journal-article","article-title":"LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer","volume":"6","author":"Liu","year":"2016","journal-title":"Scientific Reports"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s1471-4914(03)00163-1","type":"journal-article","article-title":"Intracellular antibodies and challenges facing their use as therapeutic agents","volume":"9","author":"Lobato","year":"2003","journal-title":"Trends in Molecular Medicine"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06039-w","type":"journal-article","article-title":"LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1","volume":"14","author":"Lu","year":"2023","journal-title":"Cell Death & Disease"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1128\/mcb.9.5.2124-2132.1989","type":"journal-article","article-title":"The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein","volume":"9","author":"McGuire","year":"1989","journal-title":"Molecular and Cellular Biology"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"9585","DOI":"10.1073\/pnas.92.21.9585","type":"journal-article","article-title":"Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1","volume":"92","author":"Osada","year":"1995","journal-title":"PNAS"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00525-x","type":"journal-article","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro","year":"2024","journal-title":"Nature Reviews. Disease Primers"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","type":"journal-article","article-title":"Targeted protein degradation: elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Current Opinion in Chemical Biology"},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05707-2","type":"journal-article","article-title":"Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment","volume":"9","author":"Quevedo","year":"2018","journal-title":"Nature Communications"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0092-8674(91)90057-6","type":"journal-article","article-title":"Translocations, master genes, and differences between the origins of acute and chronic leukemias","volume":"67","author":"Rabbitts","year":"1991","journal-title":"Cell"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cell.2009.04.034","type":"journal-article","article-title":"Commonality but diversity in cancer gene fusions","volume":"137","author":"Rabbitts","year":"2009","journal-title":"Cell"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1002\/anie.201611281","type":"journal-article","article-title":"Degradation of the BAF complex factor BRD9 by heterobifunctional ligands","volume":"56","author":"Remillard","year":"2017","journal-title":"Angewandte Chemie"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.1241318","type":"journal-article","article-title":"Genetics: a story of swapped ends","volume":"340","author":"Rowley","year":"2013","journal-title":"Science"},{"key":"bib32","first-page":"1887","type":"journal-article","article-title":"TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11)","volume":"6","author":"Royer-Pokora","year":"1991","journal-title":"Oncogene"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","type":"journal-article","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"PNAS"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.1038\/srep03643","type":"journal-article","article-title":"Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex","volume":"4","author":"Sewell","year":"2014","journal-title":"Scientific Reports"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1021\/acs.jproteome.2c00092","type":"journal-article","article-title":"SimPLIT: simplified sample preparation for large-scale isobaric tagging proteomics","volume":"21","author":"Sialana","year":"2022","journal-title":"Journal of Proteome Research"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","type":"journal-article","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"PNAS"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1074\/jbc.M110.188193","type":"journal-article","article-title":"Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain","volume":"286","author":"Tanaka","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1021\/acschembio.3c00616","type":"journal-article","article-title":"Degradation by design: new cyclin k degraders from old CDK inhibitors","volume":"19","author":"Thomas","year":"2024","journal-title":"ACS Chemical Biology"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"12266","DOI":"10.1073\/pnas.97.22.12266","type":"journal-article","article-title":"Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy","volume":"97","author":"Tse","year":"2000","journal-title":"PNAS"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1093\/emboj\/16.11.3145","type":"journal-article","article-title":"The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1\/NLI proteins","volume":"16","author":"Wadman","year":"1997","journal-title":"The EMBO Journal"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0092-8674(94)90571-1","type":"journal-article","article-title":"The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development","volume":"78","author":"Warren","year":"1994","journal-title":"Cell"},{"key":"bib42","first-page":"3494","type":"journal-article","article-title":"Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole-body irradiation","volume":"38","author":"Watanabe","year":"1978","journal-title":"Cancer Research"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0092-8674(84)90078-3","type":"journal-article","article-title":"New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia","volume":"36","author":"Williams","year":"1984","journal-title":"Cell"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1098\/rstb.1989.0066","type":"journal-article","article-title":"Antibody engineering","volume":"324","author":"Winter","year":"1989","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1073\/pnas.95.7.3890","type":"journal-article","article-title":"The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis","volume":"95","author":"Yamada","year":"1998","journal-title":"PNAS"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1073\/pnas.97.1.320","type":"journal-article","article-title":"The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice","volume":"97","author":"Yamada","year":"2000","journal-title":"PNAS"},{"key":"bib47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11297-3","type":"journal-article","article-title":"The transcription factor complex LMO2\/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis","volume":"12","author":"Yamada","year":"2022","journal-title":"Scientific Reports"},{"key":"bib48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115754","type":"journal-article","article-title":"The involvement of ubiquitination machinery in cell cycle regulation and cancer progression","volume":"22","author":"Zou","year":"2021","journal-title":"International Journal of Molecular Sciences"}],"updated-by":[{"DOI":"10.7554\/elife.113186","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000}}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/106699\/elife-106699-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/106699\/elife-106699-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/106699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:30:11Z","timestamp":1790004611000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/106699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":48,"alternative-id":["10.7554\/eLife.106699"],"URL":"https:\/\/doi.org\/10.7554\/elife.106699","archive":["CLOCKSS"],"relation":{},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP106699"}}